VY-1706

N/A

Report date: 2025/02/06 10:38:49
NME

Base Information

Drug NameVY-1706
Drug Alias NameTau silencing gene therapy (Voyager Therapeutics)Tau knock-down program (Voyager Therapeutics)VY-1706VY1706
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAnti-TAU
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVoyager Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVoyager Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A